Cointime

Home / Arcus Biosciences / investors

Arcus Biosciences

company

Investors

Number of Lead Investors
Number of Investors
3
18
Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.
Investor Name Lead Investor Funding Round
Gilead Sciences Yes Post-IPO Equity
GV Yes Series C
Aisling Capital - Series C
Biotechnology Value Fund - Series C
Celgene - Series C
Decheng Capital - Series C
Droia Ventures - Series C
EcoR1 Capital - Series C
Foresite Capital - Series C
Hillhouse Capital Group - Series C
Invus - Series C
Leerink Partners - Series C
Taiho Ventures - Series C
The Column Group - Series C
Wellington Management - Series C
Novartis - Series B
RTA Capital - Series B
Stanford University - Series B
Cointime
İçerikler
Şirket.